Trials / Conditions / Pancreas Cancer, Duct Cell Adenocarcinoma
Pancreas Cancer, Duct Cell Adenocarcinoma
4 registered clinical trials studyying Pancreas Cancer, Duct Cell Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors NCT07145255 | MBrace Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Su NCT06913218 | Akeso | Phase 1 |
| Completed | Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcino NCT05340569 | Laval University | N/A |
| Completed | The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma NCT05025371 | Iuliu Hatieganu University of Medicine and Pharmacy | — |